Cargando…

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma

With a rapidly developing immunotherapeutic landscape for patients with metastatic clear cell renal cell carcinoma, biomarkers of efficacy are highly desirable to guide treatment strategy. Hematoxylin and eosin (H&E)-stained slides are inexpensive and widely available in pathology laboratories,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deutsch, Julie Stein, Lipson, Evan J., Danilova, Ludmila, Topalian, Suzanne L., Jedrych, Jaroslaw, Baraban, Ezra, Ged, Yasser, Singla, Nirmish, Choueiri, Toni K., Gupta, Saurabh, Motzer, Robert J., McDermott, David, Signoretti, Sabina, Atkins, Michael, Taube, Janis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975323/ https://www.ncbi.nlm.nih.gov/pubmed/36812889 http://dx.doi.org/10.1016/j.xcrm.2023.100947

Ejemplares similares

Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge
por: Scarlotta, Matthew, et al.
Publicado: (2022)

Metastasis to the Bladder: A Rare Site of Recurrence of Renal Cell Carcinoma
por: Smart, Amanda, et al.
Publicado: (2022)

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
por: Rini, Brian I, et al.
Publicado: (2022)

CLRM-09 MAPPING THE DISTRIBUTION AND CLINICAL ASSOCIATIONS OF BRAIN METASTASES IN RENAL CELL CARCINOMA
por: Kamson, David Olayinka, et al.
Publicado: (2023)

Combinatorial commutative algebra
por: Miller, Ezra, et al.
Publicado: (2005)

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma
por: Motzer, Robert J., et al.
Publicado: (2018)

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression
por: Lalani, Aly-Khan A., et al.
Publicado: (2017)

Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma
por: Motzer, Robert J, et al.
Publicado: (2022)

Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma
por: Hamieh, Lana, et al.
Publicado: (2018)

Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
por: Powles, Thomas, et al.
Publicado: (2021)

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
por: Powles, Thomas, et al.
Publicado: (2021)

Improving continence after prostatectomy: integrating magnetic resonance imaging with the Retzius-sparing approach
por: Singla, Nirmish
Publicado: (2020)

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma
por: Atkins, Michael B, et al.
Publicado: (2015)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

In Reply
por: de Velasco, Guillermo, et al.
Publicado: (2017)

Histiocytic and dendritic cell neoplasms of the mediastinum
por: Baraban, Ezra, et al.
Publicado: (2020)

Artificial urinary sphincters for male stress urinary incontinence: current perspectives
por: Cordon, Billy H, et al.
Publicado: (2016)

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma
por: Mullane, Stephanie A., et al.
Publicado: (2016)

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
por: Lipson, Evan J, et al.
Publicado: (2015)

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor–Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
por: Rini, Brian I., et al.
Publicado: (2022)

PD-1 as a potential target in cancer therapy
por: McDermott, David F, et al.
Publicado: (2013)

Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

Adrenal pheochromocytoma in a patient with Lynch Syndrome
por: Rodriguez, Katherine M., et al.
Publicado: (2022)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Ged, Yasser, et al.
Publicado: (2021)

Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts
por: Tse, Jennifer, et al.
Publicado: (2019)

Testicular Size Discrepancy in a Man Evaluated for Vasectomy
por: Singla, Nirmish, et al.
Publicado: (2016)

Evaluation of Hematuria in a Large Public Health Care System
por: Ghandour, Rashed, et al.
Publicado: (2019)

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
por: Regan, Meredith M., et al.
Publicado: (2021)

Management of metastatic renal cell carcinoma in patients with poor prognosis
por: Bullock, Andrea, et al.
Publicado: (2010)

Circulating KIM-1 is a minimally invasive biomarker correlated with treatment response to nivolumab in patients with metastatic renal cell carcinoma
por: Xu, Wenxin, et al.
Publicado: (2023)

Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair
por: Herberg, S., et al.
Publicado: (2019)

Generalized indeterminate cell histiocytosis successfully treated with methotrexate
por: Lie, Erina, et al.
Publicado: (2022)

Re: Welk, et al., an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use
por: Enikeev, Dmitry, et al.
Publicado: (2020)

Urology case reports: Rapidly growing adrenal ganglioneuroma in a young man
por: Mudalegundi, Shwetha, et al.
Publicado: (2022)

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
por: Lipson, Evan J, et al.
Publicado: (2014)

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
por: Lipson, Evan J., et al.
Publicado: (2017)

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy
por: Jackson Cullison, Stephanie R., et al.
Publicado: (2020)

Appendiceal adenocarcinoma presenting as a bladder tumor
por: Goddard, Briana, et al.
Publicado: (2022)

Advanced renal cell carcinoma and COVID-19 — a personal perspective
por: Ged, Yasser, et al.
Publicado: (2020)

Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library
por: Lee, Jeongeun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l4h0qc4v83ehq45qjqsngepao3